Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 93 entries
Sorted by: Best Match Show Resources per page
Landscape approaches: a state-of-the-art review

Cultural Transformation in the Geoscience Community AND Program Evaluation

Arts B, Buizer M, Horlings L, Ingram V.
GSID: 4E0mScTA0owJ
B Arts, M Buizer, L Horlings, V Ingram… - Annual Review of …, 2017 - annualreviews.org

Landscape approaches have become en vogue in the past couple of decades. Originating from nineteenth-century landscape geography, this renewed popularity since the 1980s is fueled by debates on—among others—nature conservation, landscape restoration, ecosystem services, competing claims on land and...

Cite
Arts, B., Buizer, M., Horlings, L., Ingram, V., Van Oosten, C., & Opdam, P. (2017). Landscape approaches: a state-of-the-art review. Annual Review of Environment and Resources, 42, 439-463.
Arts, Bas, et al. "Landscape approaches: a state-of-the-art review." Annual Review of Environment and Resources 42 (2017): 439-463.
Copy Download .nbib Format: MLA
Gagged by false misconduct claims.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Holtings L.
PMID: 27657009
Nurs Stand. 1993 Jun 23;7(40):41. doi: 10.7748/ns.7.40.41.s45.

Joe Winters (Speak up, Viewpoint, June 9) answers his own question when he asks why nurses are so reluctant to speak up for themselves. Fear of retribution, from employers and through misuse of the UKCC Code of Conduct complaints...

Cite
Holtings L. Gagged by false misconduct claims. Nurs Stand. 1993;7(40):41doi: 10.7748/ns.7.40.41.s45.
Holtings, L. (1993). Gagged by false misconduct claims. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 7(40), 41. https://doi.org/10.7748/ns.7.40.41.s45
Holtings, Linda. "Gagged by false misconduct claims." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 7,40 (1993): 41. doi: https://doi.org/10.7748/ns.7.40.41.s45
Holtings L. Gagged by false misconduct claims. Nurs Stand. 1993 Jun 23;7(40):41. doi: 10.7748/ns.7.40.41.s45. PMID: 27657009.
Copy Download .nbib Format: NLM
Correction: Do Nobel Laureates Create Prize-Winning Networks? An Analysis of Collaborative Research in Physiology or Medicine.

PloS one

Wagner CS, Horlings E, Whetsell TA, Mattsson P, Nordqvist K.
PMID: 26287689
PLoS One. 2015 Aug 19;10(8):e0136478. doi: 10.1371/journal.pone.0136478. eCollection 2015.

No abstract available.

Cite
Wagner CS, Horlings E, Whetsell TA, et al. Correction: Do Nobel Laureates Create Prize-Winning Networks? An Analysis of Collaborative Research in Physiology or Medicine. PLoS One. 2015;10(8):e0136478doi: 10.1371/journal.pone.0136478.
Wagner, C. S., Horlings, E., Whetsell, T. A., Mattsson, P., & Nordqvist, K. (2015). Correction: Do Nobel Laureates Create Prize-Winning Networks? An Analysis of Collaborative Research in Physiology or Medicine. PloS one, 10(8), e0136478. https://doi.org/10.1371/journal.pone.0136478
Wagner, Caroline S, et al. "Correction: Do Nobel Laureates Create Prize-Winning Networks? An Analysis of Collaborative Research in Physiology or Medicine." PloS one vol. 10,8 (2015): e0136478. doi: https://doi.org/10.1371/journal.pone.0136478
Wagner CS, Horlings E, Whetsell TA, Mattsson P, Nordqvist K. Correction: Do Nobel Laureates Create Prize-Winning Networks? An Analysis of Collaborative Research in Physiology or Medicine. PLoS One. 2015 Aug 19;10(8):e0136478. doi: 10.1371/journal.pone.0136478. eCollection 2015. PMID: 26287689; PMCID: PMC4545824.
Copy Download .nbib Format: NLM
[Glimpses from a study trip].

Svenska lakartidningen

THORLING L.
PMID: 13077328
Sven Lakartidn. 1953 May 15;50(20):1092-7.

No abstract available.

Cite
THORLING L. Glimtar fran en studieresa. [Glimpses from a study trip]. Sven Lakartidn. 1953;50(20):1092-7
THORLING, L. (1953). Glimtar fran en studieresa. [Glimpses from a study trip]. Svenska lakartidningen, 50(20), 1092-7.
THORLING, L. "Glimtar fran en studieresa." [Glimpses from a study trip]. Svenska lakartidningen vol. 50,20 (1953): 1092-7.
THORLING L. Glimtar fran en studieresa. [Glimpses from a study trip]. Sven Lakartidn. 1953 May 15;50(20):1092-7. Undetermined. PMID: 13077328.
Copy Download .nbib Format: NLM
A response to Staller & Koerner-We do need to talk about restraint.

Journal of psychiatric and mental health nursing

Hollins L, Seagrave L, Stubbs B.
PMID: 34726805
J Psychiatr Ment Health Nurs. 2021 Nov 02; doi: 10.1111/jpm.12803. Epub 2021 Nov 02.

No abstract available.

Cite
Hollins L, Seagrave L, Stubbs B. A response to Staller & Koerner-We do need to talk about restraint. J Psychiatr Ment Health Nurs. 2021;doi: 10.1111/jpm.12803.
Hollins, L., Seagrave, L., & Stubbs, B. (2021). A response to Staller & Koerner-We do need to talk about restraint. Journal of psychiatric and mental health nursing, . https://doi.org/10.1111/jpm.12803
Hollins, Lee, et al. "A response to Staller & Koerner-We do need to talk about restraint." Journal of psychiatric and mental health nursing vol. (2021). doi: https://doi.org/10.1111/jpm.12803
Hollins L, Seagrave L, Stubbs B. A response to Staller & Koerner-We do need to talk about restraint. J Psychiatr Ment Health Nurs. 2021 Nov 02; doi: 10.1111/jpm.12803. Epub 2021 Nov 02. PMID: 34726805.
Copy Download .nbib Format: NLM
Recent advancements and application of in vitro models for predicting inhalation toxicity in humans.

Toxicology in vitro : an international journal published in association with BIBRA

Bedford R, Perkins E, Clements J, Hollings M.
PMID: 34920082
Toxicol In Vitro. 2021 Dec 15;79:105299. doi: 10.1016/j.tiv.2021.105299. Epub 2021 Dec 15.

Animals have been indispensable in testing chemicals that can pose a risk to human health, including those delivered by inhalation. In recent years, the combination of societal debate on the use of animals in research and testing, the drive...

Cite
Bedford R, Perkins E, Clements J, et al. Recent advancements and application of in vitro models for predicting inhalation toxicity in humans. Toxicol In Vitro. 2021;79:105299doi: 10.1016/j.tiv.2021.105299.
Bedford, R., Perkins, E., Clements, J., & Hollings, M. (2021). Recent advancements and application of in vitro models for predicting inhalation toxicity in humans. Toxicology in vitro : an international journal published in association with BIBRA, 79105299. https://doi.org/10.1016/j.tiv.2021.105299
Bedford, R, et al. "Recent advancements and application of in vitro models for predicting inhalation toxicity in humans." Toxicology in vitro : an international journal published in association with BIBRA vol. 79 (2021): 105299. doi: https://doi.org/10.1016/j.tiv.2021.105299
Bedford R, Perkins E, Clements J, Hollings M. Recent advancements and application of in vitro models for predicting inhalation toxicity in humans. Toxicol In Vitro. 2021 Dec 15;79:105299. doi: 10.1016/j.tiv.2021.105299. Epub 2021 Dec 15. PMID: 34920082.
Copy Download .nbib Format: NLM
Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular Dystrophy.

Journal of neuromuscular diseases

Tankink M, Horlings CGC, Voermans N, van der Sluijs B, Kessels RPC, van Engelen B, Raaphorst J.
PMID: 34334411
J Neuromuscul Dis. 2021 Jul 28; doi: 10.3233/JND-200592. Epub 2021 Jul 28.

Some patients with Oculopharyngeal Muscular Dystrophy (OPMD) develop frontotemporal dementia (FTD). The prevalence and clinical correlates of behavioural impairment, including FTD, is unknown in OPMD.24 OPMD patients and their proxies completed a questionnaire concerning behavioural impairment (ALS-FTD-Q). We examined...

Cite
Tankink M, Horlings CGC, Voermans N, et al. Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular Dystrophy. J Neuromuscul Dis. 2021;doi: 10.3233/JND-200592.
Tankink, M., Horlings, C. G. C., Voermans, N., van der Sluijs, B., Kessels, R. P. C., van Engelen, B., & Raaphorst, J. (2021). Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular Dystrophy. Journal of neuromuscular diseases, . https://doi.org/10.3233/JND-200592
Tankink, Maurits, et al. "Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular Dystrophy." Journal of neuromuscular diseases vol. (2021). doi: https://doi.org/10.3233/JND-200592
Tankink M, Horlings CGC, Voermans N, van der Sluijs B, Kessels RPC, van Engelen B, Raaphorst J. Behavioural Impairment and Frontotemporal Dementia in Oculopharyngeal Muscular Dystrophy. J Neuromuscul Dis. 2021 Jul 28; doi: 10.3233/JND-200592. Epub 2021 Jul 28. PMID: 34334411.
Copy Download .nbib Format: NLM
Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector.

Molecular therapy. Methods & clinical development

Carestia A, Kim SJ, Horling F, Rottensteiner H, Lubich C, Reipert BM, Crowe BA, Jenne CN.
PMID: 33376758
Mol Ther Methods Clin Dev. 2020 Nov 04;20:95-108. doi: 10.1016/j.omtm.2020.10.023. eCollection 2021 Mar 12.

Adeno-associated viruses (AAVs) are emerging as one of the vehicles of choice for gene therapy. However, the potential immunogenicity of these vectors is a major limitation of their use, leading to the necessity of a better understanding of how...

Cite
Carestia A, Kim SJ, Horling F, et al. Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector. Mol Ther Methods Clin Dev. 2020;20:95-108doi: 10.1016/j.omtm.2020.10.023.
Carestia, A., Kim, S. J., Horling, F., Rottensteiner, H., Lubich, C., Reipert, B. M., Crowe, B. A., & Jenne, C. N. (2021). Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector. Molecular therapy. Methods & clinical development, 2095-108. https://doi.org/10.1016/j.omtm.2020.10.023
Carestia, Agostina, et al. "Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector." Molecular therapy. Methods & clinical development vol. 20 (2021): 95-108. doi: https://doi.org/10.1016/j.omtm.2020.10.023
Carestia A, Kim SJ, Horling F, Rottensteiner H, Lubich C, Reipert BM, Crowe BA, Jenne CN. Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector. Mol Ther Methods Clin Dev. 2020 Nov 04;20:95-108. doi: 10.1016/j.omtm.2020.10.023. eCollection 2021 Mar 12. PMID: 33376758; PMCID: PMC7750493.
Copy Download .nbib Format: NLM
Extended liver resection including hypertrophy concept with portal venous embolisation for giant haemangioma. Too much surgery?.

Annals of hepato-biliary-pancreatic surgery

Strohmaier A, Wagner KC, Reese T, Fard-Aghaie M, Makridis G, Rittberg YV, Horling K, Oldhafer KJ.
PMID: 32843605
Ann Hepatobiliary Pancreat Surg. 2020 Aug 31;24(3):357-361. doi: 10.14701/ahbps.2020.24.3.357.

Haemangiomas of the liver are benign tumours, which are often diagnosed randomly. With an increase in size haemangiomas could become symptomatic. In this case therapeutic options, surgical or interventional, have to be weighted to a conservative approach. We present...

Cite
Strohmaier A, Wagner KC, Reese T, et al. Extended liver resection including hypertrophy concept with portal venous embolisation for giant haemangioma. Too much surgery?. Ann Hepatobiliary Pancreat Surg. 2020;24(3):357-361doi: 10.14701/ahbps.2020.24.3.357.
Strohmaier, A., Wagner, K. C., Reese, T., Fard-Aghaie, M., Makridis, G., Rittberg, Y. V., Horling, K., & Oldhafer, K. J. (2020). Extended liver resection including hypertrophy concept with portal venous embolisation for giant haemangioma. Too much surgery?. Annals of hepato-biliary-pancreatic surgery, 24(3), 357-361. https://doi.org/10.14701/ahbps.2020.24.3.357
Strohmaier, Alina, et al. "Extended liver resection including hypertrophy concept with portal venous embolisation for giant haemangioma. Too much surgery?." Annals of hepato-biliary-pancreatic surgery vol. 24,3 (2020): 357-361. doi: https://doi.org/10.14701/ahbps.2020.24.3.357
Strohmaier A, Wagner KC, Reese T, Fard-Aghaie M, Makridis G, Rittberg YV, Horling K, Oldhafer KJ. Extended liver resection including hypertrophy concept with portal venous embolisation for giant haemangioma. Too much surgery?. Ann Hepatobiliary Pancreat Surg. 2020 Aug 31;24(3):357-361. doi: 10.14701/ahbps.2020.24.3.357. PMID: 32843605; PMCID: PMC7452802.
Copy Download .nbib Format: NLM
Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy.

Neuromuscular disorders : NMD

Vincenten SCC, Mul K, Schreuder THA, Voermans NC, Horlings CGC, van Engelen BGM.
PMID: 34407911
Neuromuscul Disord. 2021 Sep;31(9):824-828. doi: 10.1016/j.nmd.2021.07.005. Epub 2021 Jul 16.

Despite the growing knowledge on the (epi)genetic background of facioscapulohumeral muscular dystrophy (FSHD), the substantial variability in disease severity that exists between FSHD patients is not fully understood. We hypothesized that smoking and alcohol consumption are disease modifiers in...

Cite
Vincenten SCC, Mul K, Schreuder THA, et al. Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2021;31(9):824-828doi: 10.1016/j.nmd.2021.07.005.
Vincenten, S. C. C., Mul, K., Schreuder, T. H. A., Voermans, N. C., Horlings, C. G. C., & van Engelen, B. G. M. (2021). Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy. Neuromuscular disorders : NMD, 31(9), 824-828. https://doi.org/10.1016/j.nmd.2021.07.005
Vincenten, Sanne C C, et al. "Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy." Neuromuscular disorders : NMD vol. 31,9 (2021): 824-828. doi: https://doi.org/10.1016/j.nmd.2021.07.005
Vincenten SCC, Mul K, Schreuder THA, Voermans NC, Horlings CGC, van Engelen BGM. Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2021 Sep;31(9):824-828. doi: 10.1016/j.nmd.2021.07.005. Epub 2021 Jul 16. PMID: 34407911.
Copy Download .nbib Format: NLM
Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system.

Toxicology reports

Keyser BM, Leverette R, Hollings M, Seymour A, Reeve L, Fields W.
PMID: 31828014
Toxicol Rep. 2019 Nov 04;6:1281-1288. doi: 10.1016/j.toxrep.2019.10.011. eCollection 2019.

The Vitrocell® VC10® smoke exposure system offers multiple platforms for air liquid interface (ALI) and air agar interface (AAI) exposure that mimic

Cite
Keyser BM, Leverette R, Hollings M, et al. Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system. Toxicol Rep. 2019;6:1281-1288doi: 10.1016/j.toxrep.2019.10.011.
Keyser, B. M., Leverette, R., Hollings, M., Seymour, A., Reeve, L., & Fields, W. (2019). Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system. Toxicology reports, 61281-1288. https://doi.org/10.1016/j.toxrep.2019.10.011
Keyser, Brian M, et al. "Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system." Toxicology reports vol. 6 (2019): 1281-1288. doi: https://doi.org/10.1016/j.toxrep.2019.10.011
Keyser BM, Leverette R, Hollings M, Seymour A, Reeve L, Fields W. Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system. Toxicol Rep. 2019 Nov 04;6:1281-1288. doi: 10.1016/j.toxrep.2019.10.011. eCollection 2019. PMID: 31828014; PMCID: PMC6889780.
Copy Download .nbib Format: NLM
Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy.

Neurology

Kroon RHMJM, Kalf JG, de Swart BJM, van der Sluijs BM, Glennon JC, Raz V, van Engelen BG, Horlings CGC.
PMID: 34380753
Neurology. 2021 Aug 11; doi: 10.1212/WNL.0000000000012640. Epub 2021 Aug 11.

ObjectiveOculopharyngeal muscular dystrophy (OPMD) is a late-onset, progressive muscle disease. Disease progression is known to be slow, but details on the natural history remain unknown. We aimed to examine the natural history of OPMD in a large nationwide cohort...

Cite
Kroon RHMJM, Kalf JG, de Swart BJM, et al. Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy. Neurology. 2021;doi: 10.1212/WNL.0000000000012640.
Kroon, R. H. M. J. M., Kalf, J. G., de Swart, B. J. M., van der Sluijs, B. M., Glennon, J. C., Raz, V., van Engelen, B. G., & Horlings, C. G. C. (2021). Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy. Neurology, . https://doi.org/10.1212/WNL.0000000000012640
Kroon, Rosemarie H M J M, et al. "Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy." Neurology vol. (2021). doi: https://doi.org/10.1212/WNL.0000000000012640
Kroon RHMJM, Kalf JG, de Swart BJM, van der Sluijs BM, Glennon JC, Raz V, van Engelen BG, Horlings CGC. Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy. Neurology. 2021 Aug 11; doi: 10.1212/WNL.0000000000012640. Epub 2021 Aug 11. PMID: 34380753; PMCID: PMC8575133.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 93 entries